FDA - Additional Steps to Advance Decentralised Clinical Trials

10th May 2023

FDA is taking additional steps to support the use of decentralised clinical trials (DCTs) for drugs, biologics and devices, where some or all the trial-related activities occur at locations other than traditional clinical trial sites. 

Read More

Back to News Archive